Enterprise Solutions Webinars
-
How To Select Your DSP Chromatography Technology
10/16/2024
Watch to explore the differences between the conventional single-column batch method and the multi-column approach for mAb capture.
-
Meeting Needs And Exceeding Expectations Worldwide
10/16/2024
Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.
-
Simtra Brand Anthem Video
10/16/2024
You can count on our extensive scientific and manufacturing expertise, stringent quality standards, and highly responsive customer service to ensure timely delivery of your life-changing products.
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
10/16/2024
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
Boston, MA: Process, Analytical Development, And Manufacturing Facility
10/16/2024
Focusing on biologics, vaccines, nucleic acids, and gene therapy, our Boston facility is now a commercially licensed site boasting a 10x 2,000L drug substance manufacturing capacity.
-
Alachua Campus Tour Video
10/16/2024
See how Resilience prioritizes agile supply chains to ensure health security and swiftly respond to emerging needs, positioning itself as a leader in biomanufacturing excellence.
-
Innovative Contamination Control: Enabling Integrity And Efficiency
10/15/2024
An integrated approach can enhance contamination control, boost process efficiency, and ensure the production of high-quality cell therapy products.
-
Microbiology Testing Systems Maintenance & Repair Services Plans
10/8/2024
Watch to learn about microbiology testing systems maintenance and repair services plans from a company with proven expertise.
-
The Peptide Promise With NervGen's Mike Kelly
10/6/2024
Mike Kelly faced a self-reckoning before he took the job as CEO at NervGen Pharma, a company developing peptide therapeutics targeted specifically at central nervous system repair. The veteran of life sciences business development knew the ropes of the biotech C-suite. He’d been a CEO twice before. He knew how to launch drugs. He even knew how to sell them. On this episode of the Business of Biotech, we learn how Kelly reconciled that truth, and how NervGen is now leading the way for peptide therapeutics in spinal cord injury and beyond.
-
Mastering The Art Of Developing A Successful Bispecific Antibody
10/3/2024
Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.